SAN ANTONIO (AP) - In a Dec. 9 story about Novartis AG's Reclast drug, The Associated Press erroneously described it as a twice-a-year treatment for osteoporosis. Reclast is given as an infusion once every two years for preventing osteoporosis in older women, and once a year to treat the disease.